Abstract
Type 1 or insulin-dependent diabetes mellitus is a syndrome of chronic hyperglycaemia secondary to insulin deficiency due to the selective destruction of the pancreatic islet β cells. The molecular pathology of the disease in humans is still poorly understood, but a substantial body of evidence favours the view that the β cells are destroyed by an autoimmune process initiated in genetically predisposed individuals by environmental agents such as viruses or chemotoxins (EISENBARTH 1986; ROSSINI et al. 1988; CAMPBELL and HARRISON 1989). Evidence in humans for the autoimmune basis of type 1 diabetes includes the following: (a) the presence of circulating autoantibodies to islet cells and/or insulin in the majority of newly diagnosed patients (GLEICHMANN and BOTTAZZO 1987), (b) mononuclear cell infiltration or “insulitis” of islets seen in the pancreas obtained at autopsy from newly diagnosed subjects (GEPTS and LE COMPTE 1981; FOULIS et al. 1986), (c) recurrence of diabetes associated with insulitis in recipients of pancreas isografts from major histocompatibility complex (MHC) identical siblings (SIBLEY et al. 1985) and (d) an increase in the frequency and duration of remissions from insulin dependence in newly diagnosed patients treated with immunosuppressive agents (HARRISON et al. 1985; ASSAN et al. 1985).
The authors are supported by the National Health and Medical Research Council of Australia and grants from Apex-Diabetes Australia, the Juvenile Diabetes Foundation and the Kellion Foundation
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adams TE, Alpert S, Hanahan D (1987) Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic β cells. Nature 325: 223–228
Allison J, Campbell IL, Morahan G, Mandel TE, Harrison LC, Miller JFAP (1988) Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic P cells. Nature 333: 529–533
Alpert S, Hanahan D, Teitelman G (1988) Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Cell 53: 295–308
Andersson M, Pääbo S, Nilsson T, Peterson P (1985) Impaired intracellular transport of class I MHC antigens as a possible means for adnenovirus to evade immune surveillance. Cell 43: 215–222
Assan R, Feutren G, Debray-Sachs M, Quiniou-Debrie MC, Laborie C, Thomas G, Chatenoud L, Bach JF (1985) Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus. Lancet 1: 67–71
Baekkeskov S, Kanatsuna T, Klareskog L, Nielsen DA, Peterson A, Rubenstein AH, Steiner DF, Lernmark A (1981) Expression of major histocompatibility antigens on pancreatic islet cells. Proc Natl Acad Sci USA 78: 6456–6460
Bendelac A, Carnaud C, Boitard C, Bach JF (1987) Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2 + T cells. J Exp Med 166: 823–832
Billingham RE, Breur L, Medawar PB (1953) “Actively acquired tolerance” of foreign cells. Nature 172: 603–606
Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512–518
Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M (1983) Hypothesis: role of aberrant HLA- DR expression and antigen presentation in the induction of endocrine autoimmunity. Lancet 2: 1115
Bottazzo GF, Dean BM, McNally JM, Mackay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 31: 353–360
Brinster RL, Chen HY, Trumbauer ME, Yagle MK, Palmiter RD (1985) Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci USA 82: 4438–4442
Campbell IL, Harrison LC (1989) Molecular pathology of type 1 diabetes. Mol Biol Med (in press)
Campbell IL, Wong GHW, Schräder JW, Harrison LC (1985) Interferon-γ enhances the expression of the major histocompatibility class I antigens on mouse pancreatic beta cells. Diabetes 34: 1205–1209
Campbell IL, Harrison LC, Ashcroft RG, Jack I (1988a) Reo virus infection enhances expression of class I MHC proteins on human ß-cell and rat RINm5F cell. Diabetes 37: 362–365
Campbell IL, Oxbrow L, West J, Harrison LC (1988b) Regulation of MHC protein expression in pancreatic beta cells by interferon-y and tumor necrosis factor-α. Mol Endocrinol 2: 101–107
Campbell IL, Iscaro A, Harrison LC (1988c) Interferon-γ and tumor necrosis factor-α: cytotoxicity to murine islets of Langerhans. J Immunol 141: 2325–2329
Campbell IL, Cutri A, Wilkinson D, Boyd AW, Harrison LC (1989a) Intercellular adhesion molecule-1 is induced on endocrine islet cells by cytokines but not by reovirus infection. Proc Natl Acad Sci USA 86: 4282–4286
Campbell IL, Cutri A, Wilson A, Harrison LC (1989b) Evidence of interleukin-6 production by and effects on the pancreatic beta cell. J Immunol 143: 1188–1191
Eisenbarth GS (1986) Type 1 diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360–1368
Foulis AK, Liddle CN, Farquharson MA, Richmond JA (1986) The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29: 267–274
Foulis AK, Farquharson MA, Hardman R (1987a) Aberrant expression of class II major histocompatibility complex molecules by ß cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 333–343
Foulis AK, Farquharson MA, Meager A (1987b) Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 2: 1423–1427
Garman RD, Jacobs KA, Clark SC, Raulet DH (1987) B-cell stimulating factor 2 (ß2 interferon) functions as a second signal for interleukin-2 production by mature murine T cells. Proc Natl Acad Sci USA 84: 7629–7633
Gepts W, Lecompte PM (1981) The pancreatic islets in diabetes. Am J Med 70: 105–115
Gleichman H, Bottazzo GF (1987) Islet cell and insulin autoantibodies in diabetes. Immunol Today 8:167–168
Gorsuch AN, Lister J, Dean BM, Spencer KM, McNally JM, Bottazzo GF, Cudworth AG (1981) Evidence for a long prediabetic period in type 1 (insulin-dependent) diabetes mellitus. Lancet 2:1363–1365
Hanahan D (1985) Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315: 115–122
Harrison LC, Kay TWH (1989) Strategies for intervention therapy in type 1 diabetes. In: Andreani D, Kolb H, Pozzilli P (eds) Immunotherapy of type 1 diabetes. Wiley, Chichester, pp 93–110
Harrison LC, Colman PG, Dean B, Baxter R, Martin FIR (1985) Increase in remission rate in newly diagnosed type 1 diabetic subjects treated with azathioprine. Diabetes 34: 1306–1308
Harrison LC, Campbell IL, Allison J, Miller JFAP (1989) MHC molecules and beta cell destruction: immune and non-immune mechanisms. Diabetes 38: 815–818
Koevary S, Rossini A, Stoller W, Chick W, Williams RM (1983) Passive transfer of diabetes in the BB/W rat. Science 220: 727–728
Kolb-Bachofen V, Kolb H (1989) A role for macrophages in the pathogenesis of type 1 diabetes. Autoimmunity 3: 145–155
Lafferty KJ, Andrus L, Prowse SJ (1980) Role of lymphokine and antigen in the control of specific T cell responses. Immunol Rev 51: 279–314
Lambert ME, Ronai ZA, Weinstein IB, Garrels JI (1989) Enhancement of major histocompatibility class I protein synthesis by DNA damage in cultured human fibroblasts and keratinocytes. Mol Cell Biol 9: 847–850
Leiter EH, Prochazka M, Coleman DL (1987) The non-obese diabetic (NOD) mouse. Am J Pathol 128:380–393
Like A A, Biron CA, Weringer EJ, Byman K, Srocznski E, Guberski DL (1986) Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med 164: 1145–1159
Lo D, Burkly LC, Widera G, Cowing C, Flavell RA, Palmiter R, Brinster RL (1988) Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell 53:159–168
Lotz M, Jirik F, Kabouridis P, Tsoukas C, Hirano T, Kishimoto T, Carson DA (1988) B cell stimulating factor 2/interleukin-6 is a co-stimulant for human thyrocytes and T lymphocytes. J Exp Med 167: 1253–1258
Markmann J, Lo D, Naji A, Palmiter RD, Brinster RL, Heber-Katz E (1988) Antigen presenting function of class II MHC expressing pancreatic beta cells. Nature 336: 476–479
Marliss EB, Nakhooda AF, Poussier P (1983) Clinical forms and natural history of the diabetic syndrome and insulin and glucagon secretion in the BB rat. Metabolish 32 [Suppl 1]: 11–16
Massa PT, Dorries R, ter Meulen V (1986) Viral particles induce la antigen expression on astrocytes. Nature 320: 543–546
Morahan G, Allison J, Miller JFAP (1989) Tolerance of class I histocompatibility antigens expressed extrathymically. Nature 339: 622–624
Neufeld DS, Platzer M, Da vies TF (1989) Reo virus induction of MHC class II antigen in rat thyroid cells. Endocrinology 124: 543–545
Oxbrow L, Campbell IL, Harrison LC (1988) Expression of islet cell differentiation antigens and major histocompatibility antigens on human insulinoma cells. Diabetes Res Clin Prac 5 [Suppl 1]:S140
Palmiter RD (1986) Germ-line transformation of mice. Annu Rev Genet 20: 465–499
Palmiter RD, Chen HY, Brinster RL (1982) Differential regulation of metallothionein-thymidine kinase fusion genes in transgenic mice and their offspring. Cell 29: 701–710
Parham P (1988) Intolerable secretion in tolerant transgenic mice. Nature 333: 500–503
Pujol-Borrell T, Todd I, Mala Doshi D, Gray M, Feldmann M, Bottazzo GF (1986) Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas. Clin Exp Immunol 65: 128–139
Pujol-Borrell R, Todd I, Doshi M, Bottazzo GF, Sutton R, Gray R, Adolf GR, Feldmann M (1987) HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature 326: 304–306
Rossini AA, Mordes JP, Handler ES (1988) Perspectives in diabetes: speculations on etiology of diabetes mellitus. Diabetes 37: 257–261
Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA (1988) Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 52: 773–782
Severinsson L, Peterson PA (1984) β2-microglobulin induces intracellular transport of human class I transplantation antigen heavy chains in xenopus laevis oocytes. J Cell Biol 99: 226–232
Sibley RK, Sutherland DER, Goetz F, Michael AF (1985) Recurrent diabetes mellitus in the pancreas iso- and allograft. Lab Invest 53: 132–144
Simonsen M, Skjødt K, Crone M, Sanderson A, Fujita-Yamaguchi Y, Due C, Rønne E, Linnet K, Olsson L (1985) Compound receptors in the cell membrane: ruminations from the borderland of immunology and physiology. Prog Allergy 36: 151–176
Srikanta S, Granda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS (1985) First-degree relatives of patients with type 1 diabetes mellitus. Islet cell antibodies and abnormal insulin secretion. N Engl J Med 313:461–464
Tarn AC, Smith CP, Spencer KM, Bottazzo GF, Gale EAM (1987) Type 1 (insulin-dependent) diabetes: a disease of slow clinical onset? B Med J 294: 342–345
Unanue ER, Allen PM (1987) The basis for the immuno-regulatory role of macrophages and other accessory cells. Science 236: 551–559
Walker MD, Edlund T, Boulet AM, Rutter WJ (1983) Cell-specific expression controlled by the 5’ flanking region of insulin and chymotrypsin genes. Nature 306: 557–561
Wawryk SO, Novotny JR, Wicks IP, Wilkinson D, Maher D, Salvaris E, Welch K, Fecondo J, Boyd AW (1989) The role of the LFA-l/ICAM-1 interaction in human leukocyte homing and adhesion. Immunol Rev 108: 135–161
Wicker LS, Miller BJ, Muller Y (1986) Transfer of autoimmune diabetes mellitus with splenocytes from non-obese diabetic (NOD) mice. Diabetes 35: 855–860
Wilkie TM, Brinster RL, Palmiter RD (1986) Germline and somatic mosaicism in transgenic mice. Dev Biol 118:9–18
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Allison, J., Harrison, L.C., Campbell, I.L., Miller, J.F.A.P. (1990). Major Histocompatibility Complex Molecules and the Beta Cell: Inferences from Transgenic Models. In: Dyrberg, T. (eds) The Role of Viruses and the Immune System in Diabetes Mellitus. Current Topics in Microbiology and Immunology, vol 156. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75239-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-75239-1_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-75241-4
Online ISBN: 978-3-642-75239-1
eBook Packages: Springer Book Archive